Literature DB >> 9469157

Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans.

S G Hasselbalch1, P L Madsen, G M Knudsen, S Holm, O B Paulson.   

Abstract

The lumped constant defined as the conversion factor between the net uptake of fluoro-2-deoxy-D-glucose (FDG) and glucose was calculated from global CMRglc and from positron emission tomography (PET) using FDG as tracer (CMRFDG). Fifteen healthy, normal volunteers (mean age 24 +/- 4 years) were studied. Global CBF and CMRglc were measured with the Kety-Schmidt technique using 133Xe as tracer, and values were corrected for errors from incomplete diffusion equilibrium for inert gas tracer between brain tissue and cerebral venous blood. Measurements of CMRFDG were obtained with PET using the dynamic and single-scan methods and the K1-k3 model. Measurements with the Kety-Schmidt technique and PET-FDG were performed simultaneously. Global CBF was 47.1 +/- 8.0 mL.100 g-1.min-1, and CMRglc was 22.8 +/- 4.1 mumol.100 g-1.min-1. No difference in CMRFDG was found with the two methods (17.8 +/- 1.6 and 18.2 +/- 1.3 mumol .100 g-1.min-1, dynamic and single scan methods, respectively). Accordingly, the lumped constant ranged from 0.80 +/- 0.16 to 0.82 +/- 0.15, with a mean value of 0.81 +/- 0.15. The mean ratio between phosphorylation of FDG and glucose (k3*/k3) was 0.39 +/- 0.25. The discrepancy between the lumped constant determined in this study and previously obtained values can be explained partly by methodologic problems, and we conclude that most of the discrepancy results from previous overestimation of global CBF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469157     DOI: 10.1097/00004647-199802000-00005

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  13 in total

1.  Morning-evening variation in human brain metabolism and memory circuits.

Authors:  B J Shannon; R A Dosenbach; Y Su; A G Vlassenko; L J Larson-Prior; T S Nolan; A Z Snyder; M E Raichle
Journal:  J Neurophysiol       Date:  2012-11-28       Impact factor: 2.714

2.  Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading.

Authors:  Kenji Ishibashi; Kei Wagatsuma; Kiichi Ishiwata; Kenji Ishii
Journal:  Hum Brain Mapp       Date:  2016-04-08       Impact factor: 5.038

3.  Quantitative kinetic modelling and mapping of cerebral glucose transport and metabolism using glucoCESL MRI.

Authors:  Ben R Dickie; Tao Jin; Ping Wang; Rainer Hinz; William Harris; Hervé Boutin; Geoff Jm Parker; Laura M Parkes; Julian C Matthews
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-23       Impact factor: 6.960

4.  Cerebral glucose metabolism in long-term survivors of childhood primary brain tumors treated with surgery and radiotherapy.

Authors:  Preben B Andersen; Katja Krabbe; Anne M Leffers; Marianne Schmiegelow; Søren Holm; Henning Laursen; Jørn R Müller; Olaf B Paulson
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

5.  The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation.

Authors:  Silvia Mangia; Ian A Simpson; Susan J Vannucci; Anthony Carruthers
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

6.  Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.

Authors:  Michael Gejl; Lærke Egefjord; Susanne Lerche; Kim Vang; Bo Martin Bibby; Jens Juul Holst; Annette Mengel; Niels Møller; Jørgen Rungby; Birgitte Brock; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

7.  Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.

Authors:  Michael Gejl; Susanne Lerche; Lærke Egefjord; Birgitte Brock; Niels Møller; Kim Vang; Anders B Rodell; Bo M Bibby; Jens J Holst; Jørgen Rungby; Albert Gjedde
Journal:  Front Neuroenergetics       Date:  2013-03-27

Review 8.  FDG-PET imaging in mild traumatic brain injury: a critical review.

Authors:  Kimberly R Byrnes; Colin M Wilson; Fiona Brabazon; Ramona von Leden; Jennifer S Jurgens; Terrence R Oakes; Reed G Selwyn
Journal:  Front Neuroenergetics       Date:  2014-01-09

9.  Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment.

Authors:  Michael Gejl; Birgitte Brock; Lærke Egefjord; Kim Vang; Jørgen Rungby; Albert Gjedde
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

10.  Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization?

Authors:  Jorge R Barrio; Sung-Cheng Huang; Nagichettiar Satyamurthy; Claudio S Scafoglio; Amy S Yu; Abass Alavi; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2019-11-01       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.